Epalrestat
Epalrestat N. CAS: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat è usato per prevenire, migliorare e trattare la neuropatia periferica (intorpidimento, dolore), la parestesia vibrazionale e l'anomalia cardiaca associata al diabete. SPECIFICA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat è usato per prevenire, migliorare e trattare la neuropatia periferica (intorpidimento, dolore), la parestesia vibrazionale e l'anomalia cardiaca associata al diabete. SPECIFICA
P nome roduct | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Scrivi qui il tuo messaggio e inviacelo